Epigenetics in non-small cell lung carcinomas

4Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Objective. To perform a systematic review of the main epigenetic aberrations involved in non-small cell lung carcinomas' (NSCLC) diagnosis, progression, and therapeutics. Materials and methods. We performed a systematic review of the scientific literature on lung cancer epigenetics, focusing on NSCLC. Results. Several advances in the molecular study of classical epigenetic mechanisms and massive studies of lung cancer epigenome have contributed relevant new evidence revealing that various molecular complexes are functionally influencing genetic-epigenetic and transcriptional mechanisms that promote lung tumorigenesis (initiation, promotion, and progression), and are also involved in NSCLC therapy-resistance mechanisms. Conclusion. Several epigenetic complexes and mechanisms must be analyzed and considered for the design of new and efficient therapies, which could be fundamental to develop an integrated knowledge to achieve a comprehensive lung cancer personalized medicine.

Cite

CITATION STYLE

APA

Peralta-Arrieta, I., Armas-López, L., Zúñiga, J., & ávila-Moreno, F. (2019). Epigenetics in non-small cell lung carcinomas. Salud Publica de Mexico, 61(3), 318–328. https://doi.org/10.21149/10089

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free